• RDD 2026 exhibitor preview

  As RDD 2026 is about to get underway in Phoenix, AZ, USA, some of the meeting sponsors and exhibitors are previewing their conference activities. As always, RDD is sponsored by dozens of organizations that offer… [Read more . . .]

• MannKind is developing ralinepag DPI (MNKD-1501) for United Therapeutics

  MannKind Corporation announced that it is developing a DPI formulation of MNKD-1501 ralinepag for the treatment of pulmonary arterial hypertension under an agreement with United Therapeutics under a 2018 licensing and collaboration agreement between the companies that… [Read more . . .]

• Merxin receives King’s Award for Enterprise, names new Head of Business Development

  UK-based inhaler developer Merxin Ltd  has been awarded a 2026 King’s Award for Enterprise for Innovation, the company announced. Merxin, which is headquartered in King’s Lynn, UK, was launched in 2015 . The award announcement… [Read more . . .]

• Copley Scientific introduces new SRS 100i sample recovery system for inhaler testing

   Copley Scientific has announced the launch of its SRS 100i automated sample recovery system for use with delivered dose uniformity and APSD testing set-ups, including the compendial dose uniformity sample apparatus (DUSA), the Next Generation Impactor (NGI),… [Read more . . .]

• 3P Innovation and Mikron Automation partner to offer DPI manufacturing systems

  3P innovation, which makes filling systems for dry powder inhaler blisters, and Mikron Automation, which offers device assembly systems, announced that they have partnered to provide integrated manufacturing systems for blister-based DPIs. The companies say that… [Read more . . .]

• Insilico Medicine gets clearance for Phase 1 trial of rentosertib (ISM001-055) inhalation solution

• Transpire Bio opens R&D facility in China

• FDA approves AstraZeneca’s Breztri Aerosphere budesonide / glycopyrrolate / formoterol MDI for the treatment of asthma

• Avalyn Pharma announces appointments of Adam Golden as Head of Business Development and Frank Salisbury as Senior VP, Commercial

• FDA approves Cipla’s generic of Ventolin HFA albuterol MDI

More news . . .